Pursuant to Regulation 30 of SEBI LODR Regulations, 2015, we wish to inform you that the Board at its meeting held on August 05, 2026 considered and approved the changes in board of directors ....

Filed: 05 Aug 2026, 18:23 IST Exchange: BSE Category: Management Change — Board of Directors Change

Board approved completion of Mr. Pankaj Patel's second term as Chairman and Independent Director effective Sep 11, 2026. - Mr. Patel to cease as Chairman and member of key committees on Sep 11, 2026. - Mr. Ravi Kirpalani appointed Additional Independent Director from Sep 1, 2026 to Aug 31, 2031, subject to shareholder approval. - Mr. Kirpalani to become Chairman from Sep 12, 2026, succeeding Mr. Patel. - Mr. Kirpalani has over 40 years of leadership experience in multinational companies.

Source: Original filing PDF — view on exchange portal

⚡ You're reading this after the fact — subscribers got it instantly

ISA

Indian Stock Alerts BOT

🚨 BAYERCROP — Quarterly Results

Revenue: ₹2,35,800 Cr (+12% YoY)

PAT: ₹19,200 Cr (+17% YoY)

EBITDA margin: 16.8%

Board declared ₹10/share dividend. Jio adds 8M subs.

📎 bseindia.com/xml-data/...

🎧 Audio summary ready

✓✓ 6:47 PM

🎧

Instant audio summaries2-min AI concall recap delivered with every earnings alert

📊

20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings

🔍

Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically

⚡

Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add BAYERCROP to your watchlist — all of this, automated.

14-day Pro trial · No credit card · Cancel anytime

More on Bayer Cropscience Limited

Important. The summary above is generated automatically from Bayer Cropscience Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.